QGel
Reproducing
HUMAN PHYSIOLOGY
Request Info
Reproducing
HUMAN PHYSIOLOGY
Request Info
Reproducing
HUMAN PHYSIOLOGY
Request Info
Reproducing
HUMAN PHYSIOLOGY
Request Info
Reproducing
HUMAN PHYSIOLOGY
Request Info

QGel’s synthetic and tunable extracellular matrix (ECM) technology mimics the complex physiology of the human body, enabling the growth of any human or animal tissue in vitro.

Qgel cellular assays:

  • Are fully scalable to meet industry demands
  • Have high biological relevance because they are able to recapitulate complex in vivo features
  • Support any tissue, from cell lines to patent derived tissue, including organoids
  • Provide applications from basic science to predictive assays in drug discovery

Qgel applications are used for:

Pre-clinic discovery

  • Target Identification
  • Target Validation
  • Screen Development
  • Drug Screening
  • Lead Optimization

Clinical development

  • Patient Stratification
  • Companion Diagnostics

Post Marketing

  • Personalized Medicine
    (Therapy Identification)
  • Lot Release Assays

QGel Innovation

QGel Innovation

Where in vivo science
meets in vitro innovation.

More Info

QGel Assays

Assays

QGel's approach to
Physiological Relevance.

More Info

QGel Products

Products

QGel® Assay Kits made
for workflow integration.

More Info

Targets and the Microenvironment

Cancer and the Tumor Microenvironment (TME)

More Info

Follow Us




Updates

Pharmaphorum on organoids

On , co-founder Colin Sanctuary explains how revolutionize

July 22, 2016

More Info


QGel co-founder on organoid technology

 advanced cell technology for explained to by QGel co-founder Lutolf > http://goo.gl/L7Ee3x

July 08, 2016

More Info

QGel SA
Innovation Park
EPFL Building G
1015 Lausanne, Switzerland
T +41 21 694 0707
F +41 21 560 4957

Print Directions
Google Maps

Innovating Drug Discovery
QGel enables drug development in a laboratory environment that accurately and reliably mimics the functioning of human organs, which means greater predictability of drug efficacy before the clinical phase. With an improved understanding of a drug’s potential, researchers spend more time and resources on the most promising therapies.

Innovating Diagnostics
QGel diagnostic tools test drug efficacy directly on tumor cells reproduced from biopsy, which means patients gain access to therapies tailored specifically to their disease. QGel advances patient outcomes, promoting personalised and accelerated treatments in an economically sustainable way.

Contact us

Sitemap | Privacy Policy | Legal Notice
© 2015 QGel SA, Lausanne, Switzerland
  • QGel on Twitter
  • QGel on LinkedIn
  • QGel on Vimeo
Unless otherwise specified, all product names appearing in this website are trademarks owned by or licensed to QGel Inc. Unauthorized use is prohibited.